Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jutta Bauhammer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Rheumatologie|November 18, 2025
[Risk of incident malignancies following exposure to Janus kinase inhibitors and biological DMARDs : An analysis from the RABBIT registry]Jutta Bauhammer
Zeitschrift Fur Rheumatologie|June 2, 2023
[The progress in dermatomyositis (ProDerm) study : First phase III study on the use of intravenous immunoglobulins in dermatomyositis]Jutta Bauhammer
Zeitschrift Fur Rheumatologie|July 27, 2019
[Antisynthetase syndromes]Jutta Bauhammer, Christoph Fiehn
Deutsche Medizinische Wochenschrift (1946)|April 8, 2025
[Rheumatoid Arthritis]Jutta Bauhammer, Christoph Fiehn
Zeitschrift Fur Rheumatologie|January 10, 2022
[Drug-induced osteopathy in rheumatology]Christoph Fiehn, Jutta Bauhammer
The Journal of Rheumatology|June 3, 2016
Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment ResponseJutta Bauhammer, Norbert Blank, Regina Max, et al.
The Journal of Rheumatology|November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International StudyMarco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Rheumatologie|November 18, 2025
[Risk of incident malignancies following exposure to Janus kinase inhibitors and biological DMARDs : An analysis from the RABBIT registry]Jutta Bauhammer
Zeitschrift Fur Rheumatologie|June 2, 2023
[The progress in dermatomyositis (ProDerm) study : First phase III study on the use of intravenous immunoglobulins in dermatomyositis]Jutta Bauhammer
Zeitschrift Fur Rheumatologie|July 27, 2019
[Antisynthetase syndromes]Jutta Bauhammer, Christoph Fiehn
Deutsche Medizinische Wochenschrift (1946)|April 8, 2025
[Rheumatoid Arthritis]Jutta Bauhammer, Christoph Fiehn
Zeitschrift Fur Rheumatologie|January 10, 2022
[Drug-induced osteopathy in rheumatology]Christoph Fiehn, Jutta Bauhammer
The Journal of Rheumatology|June 3, 2016
Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment ResponseJutta Bauhammer, Norbert Blank, Regina Max, et al.
The Journal of Rheumatology|November 17, 2018
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International StudyMarco Sebastiani, Konstantinos Triantafyllias, Andreina Manfredi, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.
Pageof 1